Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: What does an aborted trial tell us?

✍ Scribed by Gontero, Paolo; Fiorito, Chiara; Oderda, Marco; Pappagallo, Giovanni; Brausi, Maurizio

• Book ID: 122902727
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 319 KB
• Volume: 31
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2011.03.011